CCL2 and diabetes mellitus: The inhibition of M1 expression in the adipose tissue represses JNK activation, plasma DPP4 activity and CCL2 levels, as well as liver inflammatory cytokines expression that may ultimately attenuate insulin resistance and glucose intolerance in diabetes.